Blog: The Brain Dialogues, filtered by tag: proteomics
Gurjeet Kaur | Meet Our Researcher Series
Scientia PhD scholar in Brain Ageing and Proteomics Research Laboratory at CHeBA, Gurjeet Kaur is researching plasma proteome profiles of early-onset and late-onset Alzheimer's disease from three different cohorts for identification of potential blood-based biomarkers. Gurjeet hopes her proteomics findings from the longitudinal cohort will dissect the pathological changes and help us understand the complexity of Alzheimer's disease and further targeted drug discovery. Gurjeet is also working for the development of clinically relevant proteomics methods which will impact the mass spectrometry-… Read More
Dr Anne Poljak | Meet Our Researcher Series
For Dr Anne Poljak, finding the mechanisms underlying cognitive decline and neurodegenerative diseases such as dementia and identifying disease biomarkers are fundamental not only for a better understanding of how the brain works in health and disease, but also for treatment and management of diseases and disorders which affect memory. Understanding disease mechanisms is an essential piece of the puzzle to determine causes of cognitive decline and discover new treatment approaches. How did you get into researching the ageing brain? When I finished my undergraduate studies, I had an… Read More
Blood Test for Alzheimer’s: Close Or Hype?
This article was originally published in the The Conversation on 28 July 2016 Anyone who has ever visited a doctor’s office is familiar with the use of blood tests for the diagnosis of various diseases. Because blood comes in contact with all organs of the body, it carries markers of the health of these organs. It is an easily accessible body fluid, can be drawn repeatedly to follow the progress of a disease and, in most cases, blood tests are relatively inexpensive. It is therefore not surprising news that a possible blood test for dementia, in particular Alzheimer’s disease, gets much… Read More